Study Results of Novocure's NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer

Data Show that NovoTTF™ Therapy was Comparable to Physicians' First Chemotherapy Choice in Clinical Efficacy with Better Quality of Life Outcomes in Patients with Recurrent Glioblastoma

May 21, 2012, 10:26 ET from Novocure

$countyNameToPathMap.put("sp